See why Argus believes that Teva Pharmaceutical has made progress concerning its challenges, which are already baked into the stock price.
Jon C. Ogg Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce.com, Tesla and Teva Pharmaceutical.
Thursday's top analyst upgrades, downgrades and initiations included Applied Materials, Cisco Systems, Cognizant Technology Solutions, Costco Wholesale, Enphase Energy, Medtronic, Shopify, Starbucks, Teva Pharmaceutical and Xilinx.
24/7 Wall St. has put together a preview of Cisco, Lyft, Nvidia and a few of the other most anticipated quarterly reports due this week.
Teva Pharmaceuticals has been under fire for its role in the opioid crisis and for pricing fixing of some drugs, often at many times their market value. Is there any sign of…
Douglas A. McIntyre The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the hundreds…
